Maravai (MRVI) Director Sean Cunningham Receives RSU Award

What Happened
Sean Laurence Cunningham, a director of Maravai LifeSciences Holdings, Inc. (MRVI), received an award of 46,293 restricted stock units (RSUs) on May 26, 2026. The RSUs were granted at $0.00 per share (standard for restricted awards) and therefore have no immediate cash purchase value. Per the grant terms, the RSUs vest in full upon the earlier of one year from the grant date or the 2027 Maravai annual meeting of stockholders.

Key Details

• Transaction date: 2026-05-26; Form 4 filed: 2026-05-28 (filed timely).
• Security: 46,293 restricted stock units (RSUs); reported acquisition price: $0.00; total reported value at grant: $0.
• Vesting: RSUs vest in full upon the earlier of one year from grant or the 2027 annual meeting (footnote F1).
• Beneficial ownership note: Reporting person holds these securities for the benefit of a GTCR‑affiliated entity and disclaims pecuniary interest (footnote F2).
• Shares owned after transaction: not specified in the provided excerpt of the filing.

Context
RSUs are compensation awards that convert into actual shares only after vesting; they are not an outright purchase or sale and do not by themselves signal a buy/sell decision. The F2 disclosure indicates these RSUs are held for a GTCR‑affiliated entity (an institutional/private equity interest), so this report reflects an award tied to that relationship rather than a personal open‑market trade.